Improving participation in HIV vaccine trials through community communication.
Evaluating a Multilevel Communication Campaign to Increase HIV Vaccine Trial Enrollment
This study is working to get more people involved in early HIV vaccine trials by creating a friendly communication campaign that helps clear up misunderstandings and build trust, especially in communities that are most affected by HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11052511 on NIH RePORTER |
What this research studies
This research aims to enhance enrollment in early-stage HIV vaccine trials by developing and implementing a multilevel communication campaign. It addresses barriers such as stigma, misinformation, and the perceived urgency of HIV prevention. The approach involves community engagement and partnerships to create trust and awareness, particularly in marginalized communities disproportionately affected by HIV. The campaign will be refined based on community feedback and will include innovative strategies like consumer-driven marketing and virtual town halls.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from marginalized communities, particularly those disproportionately affected by HIV.
Not a fit: Patients who are not part of the targeted communities or those who are not interested in participating in vaccine trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased participation in HIV vaccine trials, ultimately accelerating the development of effective vaccines.
How similar studies have performed: Previous research has shown success in community engagement strategies for increasing participation in clinical trials, particularly during COVID-19 vaccine trials.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Andrasik, Michele Peake — Fred Hutchinson Cancer Center
- Study coordinator: Andrasik, Michele Peake
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.